Health Dictionary Find a Doctor

Chondrosarcoma natural history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rohan A. Bhimani, M.B.B.S., D.N.B., M.Ch.[2]

Overview

Overview

Complications that can develop as a result of chondrosarcoma are metastasis and recurrence. The prognosis of chondrosarcoma correlates with the grade and stage of the lesion at the time of diagnosis. Chondrosarcoma is associated with a 5 year survival rate of 70%. The presence of grade 3 lesions are associated with a particularly poor prognosis.

Natural History, Complications, and Prognosis

Natural History, Complications, and Prognosis

Complications

Prognosis

  • The prognosis of chondrosarcoma correlates with the grade and stage of the lesion at the time of diagnosis.[2]
    • Prognosis varies with grade:[3]
    • Grade I tumors – 90% survival at 5 years
    • Grade II tumors – 81% survival at 5 years
    • Grade III tumors – 29% survival at 5 years
  • Depending upon the subtype, prognosis vary substantially:[4]
    • Clear cell chondrosarcoma: 70% survival rate at 5 years.
    • Myxoid chondrosarcoma: 70% survival rate at 5 years.
    • Mesenchymal chondrosarcoma: < 50% survival rate at 5 years.
    • Dedifferentiated chondrosarcoma: 10% survival rate after 1 year.
  • Prognosis varies with location:[5]
References

References

  1. 1.0 1.1 Lalam RK, Cassar-Pullicino VN, Kumar N, Cool WP, Cribb GL, Mangham DC (2015). “Subcutaneous and lung metastases from chondrosarcoma of the thumb”. BJR Case Rep. 1 (3): 20150129. doi:10.1259/bjrcr.20150129. PMC 6180831. PMID 30363596.
  2. Larramendy ML, Mandahl N, Mertens F, Blomqvist C, Kivioja AH, Karaharju E; et al. (1999). “Clinical significance of genetic imbalances revealed by comparative genomic hybridization in chondrosarcomas”. Hum Pathol. 30 (10): 1247–53. PMID 10534175.
  3. Evans HL, Ayala AG, Romsdahl MM (1977). “Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading”. Cancer. 40 (2): 818–31. PMID 890662.
  4. Dorfman HD, Czerniak B. Bone Tumors. St Louis: Mosby; 1998. 353-440.
  5. Peabody, Terrance (2014). Orthopaedic oncology : primary and metastatic tumors of the skeletal system. Cham: Springer. ISBN 9783319073224.

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH